Date Filed | Type | Description |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $0.4367, valued at
$10.9k
|
|
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2022 |
4
| EISENBERG JEFFREY F (CEO) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 100,000 options
@ $1.12, valued at
$112k
|
|
03/28/2022 |
4
| PARSLOW JAMES F (CFO) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 50,000 options
@ $1.12, valued at
$56k
|
|
03/28/2022 |
4
| Lockshin Curtis (Chief Sciencific Officer) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 50,000 options
@ $1.12, valued at
$56k
|
|
12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2021 |
4
| VINOGRADOV ALEXEY ANDREEVICH (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.44, valued at
$36k
|
|
12/09/2021 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.44, valued at
$36k
|
|
12/09/2021 |
4
| Dastoor Firdaus J. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.44, valued at
$36k
|
|
12/09/2021 |
4
| Callaway James Eric (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.44, valued at
$36k
|
|
03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/08/2020 |
4
| VINOGRADOV ALEXEY ANDREEVICH (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.1, valued at
$27.5k
|
|
12/08/2020 |
4
| Logal Adam (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.1, valued at
$27.5k
|
|
12/08/2020 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.1, valued at
$27.5k
|
|
12/08/2020 |
4
| Dastoor Firdaus J. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.1, valued at
$27.5k
|
|
12/08/2020 |
4
| Callaway James Eric (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.1, valued at
$27.5k
|
|
04/02/2020 |
4/A
| Borisenko Grigory G. (Director) has filed a Form 4 on Xenetic Biosciences, Inc. |
12/06/2019 |
4
| PARSLOW JAMES F (CFO) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 80,000 options
@ $1.31, valued at
$104.8k
|
|
12/06/2019 |
4
| Logal Adam (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.31, valued at
$32.8k
|
|
12/06/2019 |
4
| Lockshin Curtis (Chief Scientific Officer) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 90,000 options
@ $1.31, valued at
$117.9k
|
|
12/06/2019 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.31, valued at
$32.8k
|
|
12/06/2019 |
4
| EISENBERG JEFFREY F (CEO) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 230,000 options
@ $1.31, valued at
$301.3k
|
|
12/06/2019 |
4
| Dastoor Firdaus J. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.31, valued at
$32.8k
|
|
12/06/2019 |
4
| Callaway James Eric (Director) has filed a Form 4 on Xenetic Biosciences, Inc.
Txns:
| Granted 25,000 options
@ $1.31, valued at
$32.8k
|
|
09/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
08/05/2019 |
3
| VINOGRADOV ALEXEY ANDREEVICH (Director) has filed a Form 3 on Xenetic Biosciences, Inc. |
|